ad image

IssueQ12019

1 / 3
Investing in Form-Fill-Seal Technology
Form-Fill-Seal

Investing in Form-Fill-Seal Technology

Lluc Mercadé

Grifols

PAP-Q1-2019-CL-011Apr 12, 2019
Aligning the Outsourcing Relationship
Outsourcing

Aligning the Outsourcing Relationship

Servier

PAP-Q1-2019-CL-006Apr 12, 2019
Adjusting Internal Structure to Better Meet Demands of Unmet Business
Commercialization

Adjusting Internal Structure to Better Meet Demands of Unmet Business

James E. Gregory

UPM Pharmaceuticals

PAP-Q1-2019-CL-009Apr 12, 2019
Developing and Characterizing DPI Formulations for Biologics
Formulation

Developing and Characterizing DPI Formulations for Biologics

Eunice Costa; Constança Cacela

Hovione

PAP-Q1-2019-CL-002Apr 12, 2019
Pharma Tackles the Big Issues
Nice Insight Overview

Pharma Tackles the Big Issues

Nigel Walker

Nice Insight

PAP-Q1-2019-NI-003Mar 12, 2019
Integrated Clinical Packaging, Warehousing and Transport Services Supporting Pharma and Biopharma
Supply Chain Solutions

Integrated Clinical Packaging, Warehousing and Transport Services Supporting Pharma and Biopharma

Gulam Jaffer

Yourway

PAP-Q1-2019-CL-008Mar 12, 2019
How Agile Investment Drives Innovation
Investment in Innovation

How Agile Investment Drives Innovation

Thibaut Fraisse

Fareva

PAP-Q1-2019-CL-004Mar 12, 2019
Digital Droplet PCR for Viral Vector Analysis
QPCR

Digital Droplet PCR for Viral Vector Analysis

Richard Snyder, Ph.D.; Susan D'Costa, Ph.D.; Sushma Ogram, Ph.D.; Diego Matayoshi

Thermo Fisher Scientific

PAP-Q1-2019-CL-005Mar 12, 2019
Preclinical to Nearly Commercial Virus and Viral Vector Manufacturing
Viral Vectors

Preclinical to Nearly Commercial Virus and Viral Vector Manufacturing

Jean Blehaut

Axplora

PAP-Q1-2019-CL-020Mar 12, 2019
Investing in the Future of Potent Compounds
HPAPI

Investing in the Future of Potent Compounds

Frederic Desdouits

Seqens

PAP-Q1-2019-CL-028Mar 12, 2019
Leveraging Operational Simulations to Design Cell Therapy Facilities
Engineering

Leveraging Operational Simulations to Design Cell Therapy Facilities

Niranjan Kulkarni, Ph.D.

CRB USA

PAP-Q1-2019-CL-016Mar 12, 2019
A World of Opportunity: What to Expect from CPhI & P-MEC China
CPhI & P-MEC China

A World of Opportunity: What to Expect from CPhI & P-MEC China

CPhI & P-MEC China

PAP-Q1-2019-CL-015Mar 12, 2019
Driving Growth of the Cell and Gene Therapy Sector
Cell and Gene Therapy

Driving Growth of the Cell and Gene Therapy Sector

Felix Hsu

WuXi Advanced Therapies

PAP-Q1-2019-CL-012Mar 12, 2019
Balancing Ethical and Fiduciary Responsibilities in Drug Pricing
Drug Pricing

Balancing Ethical and Fiduciary Responsibilities in Drug Pricing

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

PAP-Q1-2019-NI-004Mar 12, 2019
Evolving Ethical Conduct Concerns in Clinical Trials
Clinical Trials

Evolving Ethical Conduct Concerns in Clinical Trials

Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.

Pharma's Almanac

PAP-Q1-2019-NI-005Mar 12, 2019
Reprioritizing to Bring FY2020 into Focus
Virtual Panel

Reprioritizing to Bring FY2020 into Focus

Sarath Chandar; Graeme MacLeod; Jeanne Thoma (former); Joe Rogus; John Creighton; Coralyn Gonzalez; Jon Struthers

SPI Pharma

PAP-Q1-2019-CL-032Mar 12, 2019
Rentschler Biopharma SE Sets Foot in the U.S. to Strengthen its World-Class CDMO Position
Benefitting U.S. Clients

Rentschler Biopharma SE Sets Foot in the U.S. to Strengthen its World-Class CDMO Position

Federico Pollano

Rentschler Biopharma SE

PAP-Q1-2019-CL-033Mar 12, 2019
Preparing Middle-Market Firms to Attract Investment
Attracting Investment

Preparing Middle-Market Firms to Attract Investment

Jeffrey Marlough

Castleford Capital

PAP-Q1-2019-CL-007Mar 12, 2019
Setting Expectations for Facility and Business Sales in the CDMO Sector
Facility Sales

Setting Expectations for Facility and Business Sales in the CDMO Sector

William B. Wiederseim

PharmaBioSource, Inc.

PAP-Q1-2019-CL-001Mar 12, 2019
Selecting the Right Private Equity Partner to Build a Leading Outsourcing Provider
Meet the Investor

Selecting the Right Private Equity Partner to Build a Leading Outsourcing Provider

David Q. Anderson

Ampersand Capital Partners

PAP-Q1-2019-CL-024Mar 12, 2019
1 / 3